LY3532226

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3532226, covering 2026-01-20 to 2026-01-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3532226 in Participants With Obesity [Phase 1]